Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Baillie Gifford -International All Cap. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+8.2%
YTD+13.61%
Annualized+0.1319%
Positioning StanceCONSTRUCTIVE
Market CapAll Cap
Digest Analysis
Quick Take
"The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong gains from AI-exposed semiconductor holdings."
Executive Summary
During the third quarter of 2025, the Baillie Gifford EAFE Plus All Cap Fund underperformed its benchmark with an Institutional Class return of 0.82% compared to 4.83% for the MSCI EAFE Index. The overall market backdrop saw international equities post growth, led by AI-driven technology stocks, while Europe lagged. Key positive performance contributors were ASML and TSMC, both experiencing strong demand from accelerating AI chip requirements. Detractors included Sysmex Corp, impacted by an IT migration disruption and soft Chinese healthcare market, and United Overseas Bank, which suffered from margin compression. Portfolio changes included initiating new positions in bioMérieux and CaixaBank, with no complete sales executed.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
85%
Market Conviction
High-conviction positioning: The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
85%
Growth Outlook
Market outlook remains above average conviction: The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
88%
Risk Appetite
Risk appetite posture is above average conviction: The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
30%
Capital Deployment
Capital deployment remained balanced with selective rotation across positions. The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
80%
Forward Guidance
Forward guidance signal: The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
83%
Language Signal
Tone analysis indicates above average conviction language: The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
50%
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
70%
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...
90%
Time Horizon
Investment time horizon reflects a high conviction orientation. The Baillie Gifford EAFE Plus All Cap Fund returned 0.82% in Q3 2025, trailing its benchmark's 4.83% gain due to headwinds in key healthcare and financial holdings, despite strong ...